Earlier this year, Medgadget heard from Precipio CEO Illan Danieli on how his company uses advanced diagnostics and personalized medicine to reduce the prevalence of cancer misdiagnosis. Over 1 million patients globally and about 200,000 patients in the U.S. are annually diagnosed with non-small cell lung cancer (NSCLC). This week, the company anno (Read more...)